Euro Vital Pharma Group (“EVP Group”), a portfolio company of funds advised by capiton AG ("capiton"), successfully refinanced its existing financing.
The international law firm Taylor Wessing led by its Frankfurt finance partner Ulf Gosejacob advised EVP-Group in connection with this refinancing. The pan-european mid-market debt fund Apera, together with Deutsche Bank AG and Hamburger Sparkasse, provided the financing, comprising a Unitranche loan in combination with super senior term loans and an RCF facility. The financing has been tailored to support EVP-Group’s further growth plans as well as the refinancing of recent acquisitions in Spain, the UK and Slovakia.
EVP is among Europe’s leading private label OTC healthcare specialists, offering a broad range of products across various indications. EVP is a full-service provider, featuring own R&D and distribution capabilities and has also access to dedicated own production capacities.
capiton is an independent, owner-managed private equity firm that manages a total fund volume over €1.0 billion. The investment portfolio of capiton AG currently comprises 17 medium-sized companies. As an equity partner, capiton supports management buy-outs and growth financing in established medium-sized companies.
Legal advisors of EVP:
Taylor Wessing Germany: Ulf Gosejacob (lead partner, Banking & Finance), Michael Stein (Partner, Corporate/M&A), Dr. Michael Beyer (Salary Partner, Banking & Finance), Christopher Peine (Partner, Corporate/M&A), Kian Böhmer (Senior Associate, M&A)
Taylor Wessing UK: Martin Yells (Partner, Banking & Finance), Katie Horbury (Senior Associate, Banking & Finance), Kate Bowden (Senior Associate, Banking & Finance), Jessica Richards-Webb (Associate, Banking & Finance)
Taylor Wessing Slovakia: Silvia Hlavackova (Partner, Banking & Finance); Jana Brezinova (Senior Associate, Banking & Finance); Juraj Frindrich (Partner, Corporate/M&A)
Cuatrecasas, Spain: Hector Bross (Partner, Finance), Kai Christian Fischer (Partner, Corporate/M&A) and team